Actively Recruiting
Study of Posterior Tibial Nerve Stimulation for Improving Fecal Control and Quality of Life After Rectal Cancer Surgery
Led by Althaia Xarxa Assistencial Universitària de Manresa · Updated on 2026-06-08
84
Participants Needed
2
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Rectal neoplasia is a common cancer in Spain, and the preferred treatment is total mesorectal excision TME, which improves cancer outcomes but can lead to complications such as altered bowel function known as low anterior resection syndrome LARS and erectile dysfunction. This trial aims to study the effects of posterior tibial nerve stimulation on fecal incontinence, sexual dysfunction, and quality of life in patients who have had rectal surgery for rectal neoplasia. Participants will be randomly assigned to one of two groups one receiving posterior tibial nerve stimulation at therapeutic doses, and the other receiving stimulation at subtherapeutic doses using a Beurer EM-49 digital neurostimulator. Both groups will learn how to use the device with a pelvic floor rehabilitator and will perform sessions at home following a schedule that decreases in frequency over the first year after surgery. Throughout the 12 months after surgery, participants will be assessed at one, six, and twelve months using questionnaires that measure fecal incontinence LARS and Wexner scales, sexual function, and quality of life FIQLS and QLQ-CR38. Researchers will monitor safety and effectiveness through these evaluations and a patient global impression of improvement at one year, ensuring comprehensive follow-up during the study period.
CONDITIONS
Brief Title
Efficacy and Safety of Transcutaneous Posterior Tibial Nerve Stimulation on Fecal Continence in Patients Undergoing Surgery for Rectal Neoplasia
Research Team
M
Meritxell Font
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here